2024-03-12 12:50:06 ET
Enfusion, Inc. (ENFN)
Q4 2023 Earnings Conference Call
March 12, 2024, 08:30 AM ET
Company Participants
Bill Wright - Head, IR
Oleg Movchan - CEO
Brad Herring - CFO
Neal Pawar - COO
Conference Call Participants
Michael Infante - Morgan Stanley
Dylan Becker - William Blair
Alexei Gogolev - JPMorgan
Natalie Howard - Bank of America
Gabriela Borges - Goldman Sachs
Presentation
Operator
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's Fourth and Full Year 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I'd now like to turn the call over to Bill Wright, Head of Investor Relations, to begin.
Bill Wright
Good morning, and thank you, operator. We welcome you to Enfusion's Fourth Quarter and Full Year 2023 Earnings Conference Call. Hosting today's call are Oleg Movchan, Enfusion's Chief Executive Officer; Brad Herring, Enfusion's Chief Financial Officer and Neal Pawar, Enfusion’s newly appointed Chief Operating Officer.
Please note, our quarterly shareholder letter, which includes our quarterly financial results have all been posted through our Investor Relations website. I would like to remind you that today's call may contain forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC which are available in the Investor Relations section on our website. Actual results may differ materially from any forward-looking statements we make today. These forward-looking statements speak only as of today, and the company does not assume any obligation or intent to update them following today's call except as required by law....
Read the full article on Seeking Alpha
For further details see:
Enfusion, Inc. (ENFN) Q4 2023 Earnings Call Transcript